BACKGROUND: This study reviews the impact of changing infection control practices at the Manchester Adult Cystic Fibrosis Centre (MACFC) upon the epidemiology of Burkholderia species infections. METHODS: We reviewed strain and genomovar typing of all available Burkholderia isolates at our centre between 1983-2006. RESULTS: The incidence/prevalence of infection with Burkholderia species between 1983-1990 was below 5%/9% each year. There was a rise in incidence/prevalence of Burkholderia species between 1991 and 1994 with a peak of 16.3%/31.2% in 1992. Following complete cohort segregation, the incidence has fallen to below 3% for all but one year and the prevalence has gradually reduced to 9.3% in 2005. Currently, there is an increase in the prevalence to 10.6% for the first time since 1994, predominantly due to patients with unique infections transferring into the unit from referring centres. The presence of unique strains now exceeds transmissible strains for the first time since 1991. CONCLUSIONS: Infection control measures including patient segregation have controlled spread of transmissible B. cenocepacia strains, but not the acquisition of unique strains. Unique strains of Burkholderia species now account for the majority of new infections at the Manchester Adult Cystic Fibrosis Centre.
BACKGROUND: This study reviews the impact of changing infection control practices at the Manchester Adult Cystic Fibrosis Centre (MACFC) upon the epidemiology of Burkholderia species infections. METHODS: We reviewed strain and genomovar typing of all available Burkholderia isolates at our centre between 1983-2006. RESULTS: The incidence/prevalence of infection with Burkholderia species between 1983-1990 was below 5%/9% each year. There was a rise in incidence/prevalence of Burkholderia species between 1991 and 1994 with a peak of 16.3%/31.2% in 1992. Following complete cohort segregation, the incidence has fallen to below 3% for all but one year and the prevalence has gradually reduced to 9.3% in 2005. Currently, there is an increase in the prevalence to 10.6% for the first time since 1994, predominantly due to patients with unique infections transferring into the unit from referring centres. The presence of unique strains now exceeds transmissible strains for the first time since 1991. CONCLUSIONS:Infection control measures including patient segregation have controlled spread of transmissible B. cenocepacia strains, but not the acquisition of unique strains. Unique strains of Burkholderia species now account for the majority of new infections at the Manchester Adult Cystic Fibrosis Centre.
Authors: Z V Vasiljevic; K Novovic; M Kojic; P Minic; A Sovtic; S Djukic; B Jovcic Journal: Eur J Clin Microbiol Infect Dis Date: 2016-05-13 Impact factor: 3.267
Authors: Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell Journal: J Clin Microbiol Date: 2013-09-18 Impact factor: 5.948
Authors: Josephine M Bryant; Dorothy M Grogono; Daniela Rodriguez-Rincon; Isobel Everall; Karen P Brown; Pablo Moreno; Deepshikha Verma; Emily Hill; Judith Drijkoningen; Peter Gilligan; Charles R Esther; Peadar G Noone; Olivia Giddings; Scott C Bell; Rachel Thomson; Claire E Wainwright; Chris Coulter; Sushil Pandey; Michelle E Wood; Rebecca E Stockwell; Kay A Ramsay; Laura J Sherrard; Timothy J Kidd; Nassib Jabbour; Graham R Johnson; Luke D Knibbs; Lidia Morawska; Peter D Sly; Andrew Jones; Diana Bilton; Ian Laurenson; Michael Ruddy; Stephen Bourke; Ian Cjw Bowler; Stephen J Chapman; Andrew Clayton; Mairi Cullen; Thomas Daniels; Owen Dempsey; Miles Denton; Maya Desai; Richard J Drew; Frank Edenborough; Jason Evans; Jonathan Folb; Helen Humphrey; Barbara Isalska; Søren Jensen-Fangel; Bodil Jönsson; Andrew M Jones; Terese L Katzenstein; Troels Lillebaek; Gordon MacGregor; Sarah Mayell; Michael Millar; Deborah Modha; Edward F Nash; Christopher O'Brien; Deirdre O'Brien; Chandra Ohri; Caroline S Pao; Daniel Peckham; Felicity Perrin; Audrey Perry; Tania Pressler; Laura Prtak; Tavs Qvist; Ali Robb; Helen Rodgers; Kirsten Schaffer; Nadia Shafi; Jakko van Ingen; Martin Walshaw; Danie Watson; Noreen West; Joanna Whitehouse; Charles S Haworth; Simon R Harris; Diane Ordway; Julian Parkhill; R Andres Floto Journal: Science Date: 2016-11-11 Impact factor: 47.728
Authors: Cédric Lood; Charlotte Peeters; Quentin Lamy-Besnier; Jeroen Wagemans; Daniel De Vos; Marijke Proesmans; Jean-Paul Pirnay; Fedoua Echahidi; Denis Piérard; Matthieu Thimmesch; Anca Boeras; Katrien Lagrou; Evelien De Canck; Elke De Wachter; Vera van Noort; Rob Lavigne; Peter Vandamme Journal: PLoS Pathog Date: 2021-03-15 Impact factor: 6.823
Authors: Alex Horsley; Kevin Webb; Rowland Bright-Thomas; John Govan; Andrew Jones Journal: Front Cell Infect Microbiol Date: 2011-12-21 Impact factor: 5.293